Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Transfusion in Sepsis Trial
NCT03968484Withdrawn
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2020
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
01
Overview
Randomised, open-label trial of platelets in Thrombocytopenia (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Overall Survival at 90 days. Planned start Aug 2020; status: withdrawn.
02
Drugs
platelets
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03968484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968484.